DS
Daiichi Sankyo Company, Limited
DSKYF · OTC
$18.46 +4.59% (+$0.81)
1M +1.85%
Market Cap ¥5.19T
P/E Ratio 21.30x
Div. Yield 2.76%
ROE 14.47%
Bulios Fair Price
$9.74
47.2% downside
Current Price
$18.46
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DSKYF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
59 /100
Fair P/E 21.30x
EV/EBITDA 16.22x
PEG 0.37x
Growth
94 /100
Growing EPS growth 64.67%
Rev. growth 21.76%
Book val. growth 6.32%
Profitability
47 /100
Moderate Gross margin 68.42%
Net margin 10.92%
FCF margin 0.12%
Quality
48 /100
Average ROIC 5.76%
ROE 14.47%
Asset turnover 0.55x
Debt
100 /100
Low Debt/Equity 0.29x
Current ratio 2.92x
Net debt/EBITDA -0.44x
Stability
73 /100
Stable Beta 0.12x
Rev. volatility 3.79%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DSKYF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Hiroyuki Okuzawa
Employees
20,171
Headquarters
Tokyo
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
29 SEP
Dividend Payment
Payment date
30 OCT
Earnings
Upcoming earnings report
30 MAR
Ex-Dividend
Ex-dividend date
30 MAR
Dividend Payment
Payment date